Urea
In clinical developmentAlso known as Accuzyme, AllanEnzyme, AllanfillEnzyme, Aluvea+66 more
Accuzyme, AllanEnzyme, AllanfillEnzyme, Aluvea, Amino-Cerv, Aqua Care, Aquaphilic with Urea, Atrac-Tain, CEM-Urea, Carbamide, Carbamide Peroxide Otic, Carbonyldiamide, Carmol, Cerovel, Dermasorb XM, Dermatol 10, Ear Drops, Epimide 50, Ero Ear Wax, Ethezyme, Gladase, Gladase-C, Gormel, Gormel 10, Harnstoff, Hydrasyn25, Hydro 35, Hydro 40, Karbamid, Kera Nail, Kera-42, Kerafoam, Keralac, Keratol, Keratol 40, Kerol, Kovia, Lanaphilic with Urea, Latrix, Mectalyte, Nutraplus, Panafil White, Pap-Urea, Papain-Urea, Papfyll, Paptase, Proxigel, Rea Lo 39, Rea-Lo, Remeven, U-Kera, U-Lactin, Ultra Mide, Ultralytic, Ultralytic 2, Umecta, Umecta PD, Uramaxin, Uramaxin GT, Uramaxin GT Kit, Ureacin-10, Ureacin-20, Urealac, Ureaphil, Utopic, Vanamide, X-Viate, Ziox, Panafil, Chlorophyllin Copper Complex/Papain/Urea.
Recent clinical, regulatory, research and industry developments relating to this drug.
Urea Therapy for Hyponatremia in Subarachnoid Hemorrhage
Urea for Chronic Hyponatremia: A Pilot Study
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema
Study of Gluconeogenesis in Very Low Birth Weight Infants Receiving Total Parenteral Nutrition
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- The Journal of urology1
- The New England journal of medicine1
- Abbasi SA1
- Adams KF1
- Alva AS1
- Anand I1
- Arias-Mendoza A1
- Biering-Sørensen T1
- Böhm M1
- Bonderman D1
- Brigham and Women's Hospital/Dana-Farber Cancer Institute1
- CHU de Quebec and Laval University1
- Jewish General Hospital1
- Johns Hopkins University School of Medicine1
- Mallinckrodt Institute of Radiology and Alvin J. Siteman Cancer Center1
- Memorial Sloan Kettering Cancer Center1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Urea in the shared literature.
Studied across 2 of the same disease areas as Urea in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials